Canadian Court Upholds Pfizer's Norvasc Patent
A Canadian federal court has upheld the validity of a Pfizer Inc. patent covering the active ingredient in blood pressure treatment Norvasc....To view the full article, register now.
Already a subscriber? Click here to view full article